Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

102 results about "Peg modification" patented technology

Covalent modification with PEG groups requires PEG compounds that contain a reactive or targetable functional group at one end. The simplest method to pegylate proteins, which are rich in surface primary amines, is to use a PEG compound that contains an NHS ester group at one end.

Nano-drug based on atomic layer deposition as well as preparation method and application of nano-drug

The invention provides a nano-drug based on atomic layer deposition and a preparation method of the nano-drug, mesoporous silica is taken as a carrier, bimetallic nanoparticles are precisely deposited through ALD, and chemotherapeutic drugs and antibacterial components are loaded by combining amination and targeted PEG modification, so that the following functions are realized: (1) H2O2 in a tumor microenvironment is catalyzed to generate reactive oxygen species (ROS); removing fusobacterium nucleatum and damaging a biological membrane of the fusobacterium nucleatum; (2) GSH is consumed through Fenton reaction, and tumor drug resistance is reversed; and (3) the drug is released in pH response, and tumor cells are accurately killed. The invention further provides application of the nano-drug based on atomic layer deposition in treatment of related drug-resistant colorectal cancer induced by fusobacterium nucleatum, the process is controllable, the biocompatibility is excellent, the treatment effect on the drug-resistant colorectal cancer is remarkably improved, and the nano-drug has wide clinical application prospects.
Owner:SHANXI BETHUNE HOSPITAL (SHANXI ACAD OF MEDICAL SCI SHANXI HOSPITAL OF TONGJI HOSPITAL AFFILIATED TO TONGJI MEDICAL COLLEGE OF HUAZHONG UNIV OF SCI & TECH SHANXI MEDICAL UNIV THIRD HOSPITAL SHANXI MEDICAL UNIV THIRD CLINICAL COLLEGE OF MEDICINE)

Preparation method of binary guanidyl block copolymer for human vascular endothelial cell nucleic acid delivery

The invention relates to a preparation method of a binary guanidyl block copolymer (Poly-PEG-GUA) for nucleic acid transfection of human vascular endothelial cells (HUVEC). According to the invention, N-(2-(3-carbamyl guanidyl) ethyl) methacrylamide with different proportions is subjected to reversible addition-fragmentation chain transfer (RAFT) polymerization to polyethylene glycol modified 4-cyano-4-(phenyl thioformyl sulfenyl) valeric acid (PEG-CPADN), so that five kinds of binary guanidyl block copolymers with different molecular weights are constructed; the HUVEC gene and messenger ribonucleotide (EGFP-mRNA) of green fluorescent protein are assembled in the HUVEC for screening of transfection efficiency, and the optimal molecular weight for HUVEC transfection is optimized. Experimental results show that the Poly-PEG-GUA with the molecular weight of 53575 Daltons can be used for effectively delivering green fluorescent protein (EGFP) mRNA (messenger ribonucleic acid) to HUVEC (human umbilical vein endothelial cells), and the highest transfection efficiency is shown. The optimized Poly-PEG-GUA in the invention has a certain reference value for the research and development of subsequent cardiovascular transfection products.
Owner:CHONGQING MEDICAL UNIVERSITY

Reverse osmosis membrane based on tannic acid solution activation and hydrophilic compound surface modification and preparation method thereof

The invention discloses a reverse osmosis membrane based on tannic acid solution activation and hydrophilic compound surface modification and a preparation method thereof, and belongs to the technical field of composite reverse osmosis membrane preparation. The method comprises the following steps: after an interfacial polymerization reaction is finished, activating an RO membrane by adopting an aqueous solution containing tannic acid (TA); and meanwhile, a hydrophilic compound is selected to carry out surface modification on the activated RO membrane. The unique molecular structure of the TA can improve the surface structure of the RO membrane to improve the selective permeability of the membrane on one hand, and on the other hand, in the surface modification process, more anti-pollution groups can be fixed on the surface of the RO membrane in the presence of the TA, so that the anti-pollution performance of the RO membrane is improved, the activated RO membrane is subjected to surface modification by selecting a hydrophilic compound polyethylene glycol (PEG), and the anti-pollution performance of the RO membrane is improved. A smooth hydrophilic coating is added to the surface of the RO membrane through PEG modification, so that the selective permeability and the anti-pollution performance of the membrane are improved.
Owner:NORTHWEST UNIV

Cationic lipid C6-A1, nano-liposome particles composed of cationic lipid C6-A1 and preparation method of nano-liposome particles

The invention belongs to the technical field of medicines, and discloses a cationic lipid C6-A1, a nano-liposome particle composed of the same and a preparation method of the nano-liposome particle, and the stability is improved: the stability of the nano-liposome can be remarkably improved through the structural design and PEG modification of the C6-A1 lipid, and in-vivo degradation is reduced. And the optimized preparation method and introduction of cationic lipid can improve the encapsulation efficiency of drugs and genes. And the PEG modified lipid can reduce the recognition of an immune system, prolong the circulation time of the liposome in blood and improve the targeted transmission capability. The cation characteristic of the C6-A1 is beneficial to the combination and endocytosis of the gene and a cell membrane, and the gene transfer efficiency is improved.
Owner:BEIJING UNIV OF TECH

A dirt-resistant acrylic resin, a paint, and a method for producing the same

This invention relates to the field of acrylic resin technology and discloses a stain-resistant polyethylene glycol-graphene-grafted acrylic resin coating. TEMPO-modified graphene is used as a polymerization carrier, and TEMPO free radicals serve as initiation sites to initiate in-situ chemical grafting polymerization of monomers such as n-butyl acrylate and acrylic acid on the graphene surface, resulting in a polyethylene glycol-graphene-grafted acrylic resin. The graphene is linked to the acrylic resin through polyethylene glycol molecular chains, organically combining the graphene and acrylic resin. This improves the dispersibility of graphene, overcomes its agglomeration in the acrylic resin, and significantly enhances the tensile strength and other mechanical properties of the acrylic resin. Simultaneously, the grafted polar polyethylene glycol molecular chains improve the hydrophilicity and stain resistance of the acrylic resin.
Owner:DONGGUAN WEI YI BA COATINGS CO LTD

Polyethylene glycol modified gold-manganese dioxide nanoparticles as well as preparation method and application thereof

The invention discloses a polyethylene glycol modified gold and manganese dioxide nano particle and a preparation method and application thereof, and belongs to the technical field of biological medicine, the polyethylene glycol modified gold and manganese dioxide nano particle (GMCN and PEG) has good biocompatibility under neutral physiological conditions, can relieve tumor hypoxia and increase generation of active oxygen in acidic TME, and has a good anti-tumor effect. The radiotherapy sensitivity is improved; and immune cell death is induced. Meanwhile, a cGAS-STING signal channel can be activated, dendritic cell maturation, macrophage M1 polarization and T cell infiltration are promoted, and the immunosuppression state in TME is counteracted. In addition, the GMCN-coated PEG also has an MR-CT bimodal imaging enhancement function, and integration of diagnosis and treatment is realized. The nano sensitizer disclosed by the invention has huge potential in the aspects of improving the radiotherapy curative effect, remodeling the tumor microenvironment, promoting the anti-tumor immunity, enhancing the biomedical imaging and the like.
Owner:ANHUI PROVINCIAL HOSPITAL

Nano-liposome as well as preparation method and application thereof

The invention discloses a nano-liposome and a preparation method and application thereof, and belongs to the technical field of pharmaceutical preparations, the preparation method comprises the following steps: S1, mixing soybean lecithin, cholesterol and Tween 80, dissolving in absolute ethyl alcohol, stirring until complete dissolution, and transferring the mixed solution into a rotary evaporator to obtain a lipid film; and S2, adding a resveratrol solution, a nisin solution and a 0.03 M phosphate buffer solution into the lipid membrane obtained in the step S1, after the membrane is completely dissolved, transferring to a cell superfine grinding instrument for treatment, adding a phosphatidyl ethanolamine-polyethylene glycol 2000 aqueous solution with the mass fraction of 3%, uniformly mixing by vortex, standing, and filtering by a filtering membrane to obtain the lipid membrane. The polyethylene glycol modified nano liposome RN-NPs is obtained. As an oral targeted drug delivery system, the nano-liposome disclosed by the invention not only improves the effective utilization rate of drugs, but also remarkably improves the safety and effectiveness of treating staphylococcus aureus enteritis.
Owner:QINGDAO AGRI UNIV +1

Enzyme-containing anti-inflammatory composition for pet skin and hair follicle health

The invention discloses an enzyme-containing anti-inflammatory composition for pet skin and hair follicle health. The enzyme-containing anti-inflammatory composition comprises an enzyme preparation, a hair follicle maintenance agent, a functional auxiliary agent and a carrier raw material. The core innovation lies in that a hair follicle targeted enzymolysis technology is adopted, and a specific enzyme modified by polyethylene glycol can efficiently dredge hair follicles; the anti-inflammatory and hair follicle repairing dual effects are achieved through anti-inflammatory-maintenance synergistic matching and adding sequence optimization; the damaged barrier is rapidly repaired by combining a composite barrier repairing agent and a gradient permeation process; enzyme activity and mildness are guaranteed by adopting a microcapsule embedding and low-temperature preparation technology. The composition can specifically solve the problems of hair follicle blockage, inflammation and unhairing, is suitable for pets of all ages and skin types, and is high in practicability.
Owner:ZHONGCHUANG JICHONG (SHENZHEN) TECHNOLOGY CO LTD

Carrier-free self-driven nanomotor and preparation method and application thereof

PendingCN122624644ANanomotorPhotosens
The application relates to a carrier-free self-driven nanomotor and a preparation method and application thereof, and belongs to the technical field of biological medicines. The nanomotor is a nanometer assembly formed by co-assembly of a photothermal / light motion dual-enhanced photosensitizer and a near-infrared light response type nitric oxide donor BNN6 through intermolecular force, or is a nanometer assembly formed by co-assembly of a photothermal / light motion dual-enhanced photosensitizer and a near-infrared light response type nitric oxide donor BNN6 through intermolecular force and modified by a polyethylene glycol modifier. The application realizes a synergistic treatment mode of deep tumor penetration and high-efficiency killing by constructing a functional coupling system of "photothermal driving-NO release-motion enhancement-RNS cascade generation".
Owner:SHENYANG PHARMA UNIV

Nano preparation for synergistic chemotherapy of natural product as well as preparation method and application of nano preparation

The invention discloses a nano preparation for natural product synergistic chemotherapy as well as a preparation method and application of the nano preparation, nanoparticles are formed by self-assembly of an SN38 prodrug sensitive to redox and galangin in a carrier-free manner, and can also be co-assembled nanoparticles modified by polyethylene glycol or entrapped with hydrophobic fluorescent molecules. According to the SN38 prodrug, a fluorene methanol side chain is coupled to an SN38 molecule through a redox-sensitive disulfide bond, so that a prodrug structure with a responsive release characteristic is constructed. The construction of the nano system not only significantly reduces the off-target toxicity of SN38 and improves the tolerance dose of SN38, but also enhances the SN38-mediated chemotherapy effect by the sensibilization effect of galangin, significantly improves the treatment efficiency, and realizes high-efficiency and low-toxicity cancer treatment. The invention provides a novel and synergistic prodrug nano drug delivery platform, and a new strategy is provided for precise treatment of refractory tumors.
Owner:SHENYANG PHARMA UNIV

Pegylated asparaginase and its application

The present invention discloses a PEGylated asparaginase and its application in drug preparation and clinical treatment. In the PEG-modified asparaginase of the present invention, one molecule of asparaginase is coupled with 13-45 molecules of polyethylene glycol, wherein the polyethylene glycol is a linear polyethylene glycol with an average molecular weight of 2-20 kDa. The asparaginase after PEG modification prepared by the present invention. The PEGylated asparaginase provided by the present invention has the advantages of reducing immunogenicity and significantly extending half-life, and the coupling of polyethylene glycol and asparaginase is more stable. Compared with the original research drug and generic drug products of the PEGylated asparaginase sold on the market, the PEGylated asparaginase provided by the present invention has a more stable structure, a firm PEG bond, is not easy to fall off, and has higher homogeneity and activity.
Owner:ZONHON BIOPHARMA INST

Nanoparticles and preparation method

PendingUS20260199392A1PlatinumPolymer science
The present invention relates to nanoparticles of a metal chosen from among platinum, bismuth or a mixture thereof, which are functionalised at their surface by functionalised polyethylene glycol, comprising in particular at least one OH, COOH, NH2 or SH functional group, and to their method of preparation, which comprises of the following steps:a) Mixing a precursor of nanoparticles with a functionalised polyethylene glycol, in particular comprising at least one OH, COOH, NH2 or SH functional group, in water;b) Exposing the mixture to ionising radiation.
Owner:CENT NAT DE LA RECH SCI (C N R S) +1

Hydroxyl-alpha-sanshool nano preparation as well as preparation method and application thereof

The invention discloses a hydroxyl-alpha-sanshool nano preparation as well as a preparation method and application thereof, and belongs to the technical field of pharmaceutical preparations, the hydroxyl-alpha-sanshool nano preparation is HAS-coated PEG-PLGA, the preparation method comprises the following steps: taking hydroxyl-alpha-sanshool and polyethylene glycol modified polylactic acid-glycolic acid copolymer as raw materials, and adding the hydroxyl-alpha-sanshool nano preparation and the polyethylene glycol modified polylactic acid-glycolic acid copolymer to prepare the hydroxyl-alpha-sanshool nano preparation. The preparation method comprises the following steps: preparing HAS-coated TGN-PEG-PLGA by adopting an emulsified solvent evaporation method, and further modifying by adopting TGN polypeptide, so as to prepare HAS-coated TGN-PEG-PLGA; according to the hydroxyl-alpha-sanshool nano-preparation, the encapsulation efficiency and the drug loading capacity of hydroxyl-alpha-sanshool are obviously improved, and the hydroxyl-alpha-sanshool nano-preparation has excellent stability and blood-brain barrier crossing capacity, so that the hydroxyl-alpha-sanshool nano-preparation can give full play to the treatment effects of improving learning and memory ability, cognitive ability and the like.
Owner:SICHUAN CANCER HOSPITAL

Polyethylene glycol modified quinine or its derivatives and their use in medicine

A polyethylene glycol modified kinine or its derivative and its use in drugs. The present invention uses PEG modification technology to significantly extend the half-life of kinine and simultaneously exert its biological activity, solving the problem of lack of druggability due to a short half-life. PEG modifiers include, but are not limited to, SPA, SCM, and SS modifiers. They may be linear or branched PEG modifiers. The modified kinine mutant of the present invention has an extended half-life while retaining its affinity to the receptor, and further has a better efficacy after PEG modification than wild-type kinine, further improving the druggability of kinine. The PEG modified kinine of the present invention exhibits remarkable drug efficacy even when administered by various routes. In particular, subcutaneous injection and oral administration are convenient for clinical use, effectively improve patient compliance, and are suitable for long-term treatment administration such as the recovery treatment of stroke patients.
Owner:ZONHON BIOPHARMA INST

Lipid particle

An object of the present invention is to provide a lipid particle that can be produced without using a PEG-modified lipid, or that exhibits higher drug effects, safety, or stability than those of a lipid particle produced using a PEG-modified lipid; or that has immunokinetics different from those of a lipid particle produced using a PEG-modified lipid. A lipid particle comprising an ionized lipid, a phospholipid, and a sterol as lipid components of the lipid particle, and a modified polysaccharide containing a hydrophobic group.
Owner:UNITED IMMUNITY CO LTD

Polyethylene glycol site-directed modified heteropolymer protein or polypeptide as well as preparation method and application thereof

The invention discloses a polyethylene glycol site-directed modified heteropolymer protein or polypeptide as well as a preparation method and application thereof. Firstly, a method for performing site-specific polyethylene glycol modification on protein or polypeptide is provided, and comprises the following steps: providing protein or polypeptide to be modified, the protein or polypeptide to be modified comprises a target N-terminal alpha-amino group and a non-target N-terminal alpha-amino group, and performing mutation blocking on the non-target N-terminal alpha-amino group; and carrying out site-specific modification reaction on the target N-terminal alpha-amino group and the aldehyde group or ketone group derivative of polyethylene glycol to generate the protein or polypeptide subjected to site-specific modification by polyethylene glycol. The polyethylene glycol fixed-point single-modified heteropolymer protein or polypeptide product modified by the method has a definite and controllable modification position, can bring more definite half-life period prolonging and biased composition activity, and can be better applied to drug treatment.
Owner:KANGLITAI BIOMEDICAL (QINGDAO) CO LTD

Preparation method of reusable polyethylene glycol modified magnetic beads and application of reusable polyethylene glycol modified magnetic beads in exosome extraction

The invention discloses a preparation method of reusable polyethylene glycol modified magnetic beads and application of the reusable polyethylene glycol modified magnetic beads in exosome extraction.The preparation method comprises the steps that EDC is added into carboxylated magnetic graphene oxide for a reaction, then NHS is added for a reaction, and a mixed solution is obtained; and adding an aqueous solution of aminated polyethylene glycol into the mixed solution, carrying out amidation reaction, carrying out magnetic suction washing with pure water, and drying. When the exosome is extracted by adopting the method disclosed by the invention, the exosome of 30-150nm can be obtained; the polyethylene glycol modified magnetic beads used in the invention have the advantages of low cost, fast preparation and strong magnetism, and can be completely separated from the solution within 30 s. The exosome is captured through a precipitation method, the activity of the exosome is not damaged after the exosome is released, the yield and the purity of the exosome are improved, the recovered magnetic beads can be repeatedly used, and the cost is reduced.
Owner:SUZHOU NINGRAO BIOTECHNOLOGY CO LTD

A method for preparing stable gold nanocapsules with adjustable surface properties

The invention provides a method for preparing a stable gold nanocapsule with adjustable surface properties, belonging to the field of interface modification. The method first prepares gold nanoparticles stabilized by sodium citrate, replaces the amino ligand of thiol polyethylene glycol, obtains gold nanoparticles modified by polyethylene glycol with amino groups at the end, then adds N-hydroxysuccinimide acrylate to the solution, reacts with the amino groups on the surface of the gold nanoparticles, obtains gold nanoparticles modified by polyethylene glycol with double bonds at the end, finally adds a reactive monomer, a cross-linking agent and an initiator to the solution, performs in-situ free radical polymerization, and prepares gold nanocapsules with a core-shell structure. The nanocapsules have higher stability than gold nanoparticles modified by polyethylene glycol.
Owner:JILIN UNIVERSITY

Polyethylene glycol-modified polylysine, preparation method thereof, nano vaccine and application thereof

The present invention provides polyethylene glycol-modified polylysine, its preparation method, a nanovaccine, and its application. The polyethylene glycol-modified polylysine comprises a dendritic polymer initiator and chiral polylysine linked by amide bonds. By grafting polyethylene glycol onto the side chains of polylysine, the present invention modulates charge density and enhances nanoparticle migration to lymph nodes. Finally, the nanovaccine is prepared by binding to antigens through electrostatic adsorption. Research has shown that the resulting antigen-complexed nanovaccine promotes endocytosis by antigen-presenting cells (APCs) and their migration to lymph nodes, activating immune cells there. It can stimulate dendritic cells (DCs) to mature and release inflammatory cytokines. It also promotes antigen cross-presentation by DCs in vivo, triggering a strong antigen-specific immune response.
Owner:CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES

Polyethylene glycol modified prrp31 and preparation and use thereof

This invention relates to a polyethylene glycol-modified PrRP31, its preparation, and its application. The invention involves modifying PrRP31 with polyethylene glycol and testing its anti-inflammatory activity in a mouse paw edema model and its analgesic activity in a mouse water bath tail-flick experiment. Using polyethylene glycol-modified PrRP31, a mouse paw edema model, and a water bath tail-flick experiment, the anti-inflammatory and analgesic activities of polyethylene glycol-modified PrRP31 were tested. The experiments demonstrated that polyethylene glycol-modified PrRP31 possesses good anti-inflammatory and analgesic activity. In the mouse paw edema model, polyethylene glycol-modified PrRP31 inhibited inflammation by 37.09% (5 h) at a concentration of 5 mg / kg. In the mouse water bath tail-flick experiment, polyethylene glycol-modified PrRP31 produced the maximum analgesic effect at a concentration of 5 mg / kg. This invention provides an application of polyethylene glycol-modified PrRP31 as an anti-inflammatory and analgesic drug, offering beneficial assistance in the treatment of related diseases and possessing significant importance in the pharmaceutical field.
Owner:NORTHWESTERN POLYTECHNICAL UNIV

Lipid nanoparticles

PendingUS20260248824A1NanoparticlePharmaceutical drug
Provided are lipid nanoparticles showing excellent drug migration to the pancreas.The lipid nanoparticles according to the present invention are lipid nanoparticles for delivering a drug to a target tissue, comprising: (a) a phosphatidylcholine-type phospholipid having an unsaturated fatty acid chain with 16 to 24 carbon atoms, and (b) a polyethylene glycol-modified lipid, wherein the target tissue is the pancreas.
Owner:UNIV OF SHIZUOKA +1

Benzocyclooctyne-polyethylene glycol modified halofuginone as well as preparation method and application thereof

Hydrophilic modification is carried out on halofuginone through carboxyl polyethylene glycol with a benzocyclooctyne group to obtain benzocyclooctyne-polyethylene glycol-halofuginone (CPH) with good biocompatibility, and the CPH is used for anti-tissue fibrosis treatment through glycometabolism engineering and orthogonal click chemistry. Compared with halofuginone small molecules, the CPH has negligible cytotoxicity. The combination of CPH and glycometabolism engineering has a good treatment effect on tissue fibrosis.
Owner:NANJING UNIV

PEG-modified glucocorticoid drug and application thereof

PendingCN119698425ANervous disorderAntipyreticDiseaseTracheitis
The invention provides a polyethylene glycol (PEG) modified glucocorticoid medicine and application thereof, and relates to the technical field of medicinal chemistry, and the medicine comprises but is not limited to asthma, chronic obstructive pulmonary diseases, bronchitis, rhinitis and the like. The invention relates to a polyethylene glycol modified glucocorticoid drug. The polyethylene glycol modified glucocorticoid drug comprises but is not limited to the following compounds: KYAC-03, KYAC-04, KYAC-08, KYAC-09, KYAC-10, KYAC-11, KYAC-14, KYAC-16, KYAC-17, KYAC-20, KYAC-33 and KYAC-39. An anti-asthma and allergic rhinitis pharmacological experiment shows that the PEG-modified glucocorticoid medicine provided by the invention can remarkably improve disease symptoms and signs of asthma model mice and allergic rhinitis model mice, and remarkably reduces the administration dosage of glucocorticoid, so that the side effects of the whole body are reduced.
Owner:TIANJIN PHARM BIOTECHNOLOGY CO LTD

Method for preparing polyethylene glycol-modified urate oxidase

Provided is a method for preparing a polyethylene glycol-modified urate oxidase, at least 11 of the following amino acid sites of the polyethylene glycol-modified urate oxidase have a PEG modification: T1, K3, K4, K30, K35, K76, K79, K97, K112, K116, K120, K152, K179, K222, K231, K266, K272, K285, K291, and K293, and the preparation method includes: performing a coupling reaction between urate oxidase and polyethylene glycol, wherein the polyethylene glycol is provided in the form of an acidic solution, and a molar ratio of the urate oxidase to the polyethylene glycol is 1: (56 to 94), to obtain the polyethylene glycol-modified urate oxidase.
Owner:HANGZHOU GRAND BIOLOGIC PHARMA INC

Adhesive for quickly curing tea seed cake liquid mulching film into film

InactiveCN120699451APlant protectionSurface tension gradientPhenolic content in tea
The invention relates to an adhesive for quickly curing a tea seed cake liquid mulching film into a film, which is characterized by comprising the following components in percentage by weight: 30-50% of tea seed cake extract; 5 to 15 percent of beet polysaccharide; 0.3 to 0.8 percent of nano SiO2; 0.05 to 0.2 percent of zinc humate; the adhesive comprises the following components in percentage by weight: 20-30% of beet polysaccharide, 10-20% of tea polyphenol, 10-20% of nano SiO2, 10-20% of nano SiO2 and 45-65% of water, the molar ratio of beet polysaccharide to tea polyphenol is 1: (1.5-2.2) so as to promote dynamic ester bond crosslinking, the nano SiO2 is modified by polyethylene glycol (PEG-4000), the zeta potential ranges from-25 mV to-35 mV, the nano SiO2 is used for regulating and controlling the surface tension gradient of a liquid film, and the adhesive can keep the dynamic crosslinking capacity for 72-80 hours when the pH value of soil ranges from 5.5 to 7.8. According to the adhesive for rapidly curing and forming the tea seed cake liquid mulching film, rapid curing for 35 + / -5 minutes is achieved through the catalysis of the zinc humate and the synergistic effect of the nano SiO2, compared with a traditional starch-based mulching film, the efficiency is improved, the farming operation interval is greatly shortened, a gradient pore structure is formed through induction of the nano SiO2, the surface layer is 5 microns / the bottom layer is 20 microns, wind erosion prevention and air permeability are both considered, the self-organization film forming thickness is 1.2 + / -0.3 mm, and the film forming efficiency is greatly improved. The coefficient of variation is less than 8%, and the film-forming property is excellent.
Owner:NINGBO DAHONGYING UNIV

Hypocrellin 2-position polyethylene glycol substituted water-soluble derivative and application thereof in tumor treatment

The invention discloses a water-soluble polyethylene glycol modified hypocrellin derivative and an application of the water-soluble polyethylene glycol modified hypocrellin derivative in photodynamic therapy of tumors. The maximum absorption wavelength of the prepared polyethylene glycol modified hypocrellin derivative is about 580 nm, the molar extinction coefficient can reach 15000-20000 M <-1 > cm <-1 >, and the polyethylene glycol modified hypocrellin derivative has very high light absorption capacity in a phototherapy window. Active oxygen species such as singlet oxygen can be efficiently generated under a photosensitive condition, and various tumor cells can be efficiently inactivated. The prepared polyethylene glycol modified hypocrellin derivative has good water solubility, the solubility of the derivative in normal saline is 10 mg / mL or above, and the derivative can serve as a photosensitive drug to enter a human body through caudal vein administration, can specifically gather in tumor cells or tissues and can be used for photodynamic drugs to treat various tumors. Under the same conditions, the polyethylene glycol substituted hypocrellin derivative disclosed by the invention, as a photosensitive drug, has a better photodynamic therapy effect than a porphyrin commercial photosensitive drug for treating tumors.
Owner:TECHNICAL INST OF PHYSICS & CHEMISTRY - CHINESE ACAD OF SCI

Organophosphorus poisoning rescue composite enzyme and application thereof

PendingCN122104634APeptide/protein ingredientsHydrolasesPtru catalystAcetylhomocholine
The application provides an organic phosphorus poisoning relief composite enzyme and application thereof, and belongs to the technical field of biological medicine. The organic phosphorus poisoning relief composite enzyme provided by the application comprises polyethylene glycol modified organic phosphorus hydrolase and butyrylcholine esterase, and the mass ratio of the polyethylene glycol modified organic phosphorus hydrolase to the butyrylcholine esterase is (4-8):(2500-10000). The rat acute organic phosphorus poisoning treatment result shows that the organic phosphorus poisoning relief composite enzyme provided by the application fully plays the efficient catalytic hydrolysis capacity of the enzyme as a catalyst, efficiently removes organic phosphorus and acetylcholine by using the organic phosphorus hydrolase and the butyrylcholine esterase respectively, provides a drug combination for treating the cause for the organic phosphorus poisoning injury first aid, and the treatment effect is significantly better than that of the single drug.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Immobilized enzyme as well as biological oil preparation method and device based on reusable enzyme

The invention discloses an immobilized enzyme and a biological oil production method and device based on the reusable enzyme. The immobilized enzyme takes polyethylene glycol modified Fe3O4 nanoparticles as a matrix, and the matrix adsorbs and loads a first part of free protease at first and then adsorbs and loads a second part of free protease at first; then dispersing the first part of free protease and a second part of free protease in a sodium alginate aqueous solution, uniformly mixing, sequentially carrying out two-step action processes of Ca < 2 + > ion hardening and glutaraldehyde cross-linking reaction to enable the sodium alginate on the outer layer to react to form reticular large-aperture gel microspheres, and finally washing and drying to obtain the hydrogel microspheres. And preparing to obtain a microsphere compound which is embedded with a second part of free protease and is loaded with the immobilized protease by the polyethylene glycol modified nano Fe3O4. The stability and in-situ separation convenience of the immobilized enzyme in a heterogeneous slurry-residue mixed system are greatly improved, the immobilized enzyme can be better reused, in addition, stirring blades of the biological oil making reactor are improved, and the use stability of the immobilized enzyme can be further improved.
Owner:ZHEJIANG UNIV OF TECH

Phospholipid-polyethylene glycol modified monoiodine aza-BODIPY photosensitizer as well as synthesis method and application thereof

The invention relates to the technical field of drug synthesis, and particularly provides a phospholipid-polyethylene glycol modified mono-iodine aza-BODIPY photosensitizer as well as a synthesis method and application thereof, and the phospholipid-polyethylene glycol modified mono-iodine aza-BODIPY photosensitizer has good photosensitization activity and tumor inhibition activity, and can be used for preparing drugs for treating tumors. The compound can be developed into efficient cell membrane targeted photodynamic antitumor drugs, and can be used for photodynamic therapy of non-specific wide tumors, such as pancreatic cancer, cervical cancer, brain glioma, lung cancer, gastric cancer, bladder cancer, ovarian cancer, colon cancer, skin cancer, prostatic cancer and the like.
Owner:PEOPLES HOSPITAL OF HENAN PROV

Lipid nanoparticle preparation of mRNA (messenger ribonucleic acid) nucleic acid vaccine and preparation method of lipid nanoparticle preparation

The invention relates to the field of bioengineering, and discloses an mRNA nucleic acid vaccine lipid nanoparticle preparation, which comprises the following components in percentage by total mole of lipid: dynamic pKa lipid accounting for 15-25% of the total mole of lipid; the phospholipid accounts for 25-35% of the total molar content of the lipid, the invention also discloses a preparation method of the mRNA nucleic acid vaccine lipid nanoparticle preparation, and the preparation method comprises the following steps: S1, dissolving the dynamic pKa lipid, the phospholipid, the cholesterol and the polyethylene glycol modified lipid in ethyl lactate to form an organic phase, and the total concentration of the lipid is 5-15mg / mL. By designing the dynamic pKa lipid and optimizing the preparation process, not only can the encapsulation efficiency and delivery efficiency of mRNA be remarkably improved, but also a green solvent can be used for replacing a traditional solvent, solvent residues and environmental burden are reduced, in addition, by improving the microfluidic technology, the production efficiency and consistency of LNP are improved, and the application prospect is wide. The problems of stability and consistency in a traditional LNP preparation process are solved.
Owner:HEFEI AFANA BIOTECHNOLOGY CO LTD